Clinical Trials in Alessandria, IT
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 2
Efficacy and Safety of Frontline Tislelizumab in Patients With de Novo Hodgkin Lymphoma Unsuitable for Standard Frontline Chemotherapy
Hodgkin Lymphoma
Fondazione Italiana Linfomi - ETS28 enrolled10 locationsNCT05977673
Recruiting
Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 Maintenance
Follicular Lymphoma
Fondazione Italiana Linfomi - ETS56 enrolled14 locationsNCT06070961